0995. Aspirin reduces neutrophilic pulmonary inflammation in a human model of acute respiratory distress syndrome induced by inhaled lipopolysaccharide

Samankaltaisia teoksia

• Aspirin reduces lipopolysaccharide-induced pulmonary inflammation in human models of ARDS
  Tekijä: Hamid, U, et al.
  Julkaistu: (2017)
• Mesenchymal stromal cells for treatment of the acute respiratory distress syndrome: The beginning of the story
  Tekijä: Morrison, T, et al.
  Julkaistu: (2015)
• Cigarette smokers have exaggerated alveolar barrier disruption in response to lipopolysaccharide inhalation
  Tekijä: Moazed, Farzad, et al.
  Julkaistu: (2016)
• Aspirin as a potential treatment in sepsis or acute respiratory distress syndrome
  Tekijä: Toner, Philip, et al.
  Julkaistu: (2015)
• Aspirin therapy in patients with acute respiratory distress syndrome (ARDS) is associated with reduced intensive care unit mortality: a prospective analysis
  Tekijä: Boyle, Andrew J, et al.
  Julkaistu: (2015)